We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Stressgen (VSE: SSB)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
236 8 0 SSB
Emcee:  Andy Patton Type:  Unmoderated
Is anyone out there following Stressgen (SSB on TSE)?

Stressgen is developing drugs based on stress proteins, which are
produced naturally by cells when they are under attack or stress.
Trials on rats with Stressgen products have produced elevated immune response for over a year now (!) as well as tumour suppression.

Possible uses for stress protein products (often spliced onto viral bits): anti-cancer and (which interests me most) a replacement for antibiotics (which have by now created new strains of drug-resistant bugs.)

It appears that Stressgen's research also has diagnostic possibilities: their work suggests the possibility of using the analysis of the production of these proteins to study the effect of environmental pollution on human subjects. (The relation between amounts of a pollutant in the environment and its effect on a living person isn't linear; study of stress protein production can be an avenue for the assessing of the degree of effect of a certain concentration of a pollutant in the environment.)

The company has an interesting web site:

lots of the science here as well as info on the company and its principals. Company also has a revenue stream from production and sale of protein reagents (in 26 countries?). Seems to have this niche to itself at the moment.

I've invested in it (small position) as its research interests me, but I'm not capable of assessing the science behind it. Is there anyone out there who has any knowledge of either this field or Stressgen's work in particular?

Thanks for any help you can offer.

-Andy Patton
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
236To all: manufacturing completed for phase III RRP trial <i>Stressgen BiotHeat Shock-6/21/2005
235Stressgen forced to slash staff Millions lost in last five years Darron Klostertnsaf-4/29/2005
234To all, 2 Press Releases today: Stressgen announces sale of bioreagents busiHeat Shock-4/14/2005
233Still waiting for the financing information to come out. In the meantime, todayHeat Shock-3/21/2005
232Today's Press release: <i>Stressgen Announces End-of-Phase II MeetinHeat Shock-6/30/2004
231To all: here is some text from Stressgen's latest 10-K about the terms of itHeat Shock-5/12/2004
230To all: Post #7866162 on by immunoirving: <i>IMHO: 1. PartnHeat Shock-5/10/2004
229Re the recent conference call- here is post 7856537 by grisled on Shock-5/7/2004
228To all, the unfortunate endpoints in the Anal Dysplasia PII Clinical Trial sure Heat Shock-4/20/2004
227David, It's RRP. Re-read the previous post. The strategy I mentioned is smHeat Shock-2/29/2004
226Is RRR market very bigDavid Culver-2/27/2004
225David, The results in two trials were reported. The RRP (recurrent respiratoryHeat Shock-2/26/2004
224Does not seem like good news thought this company had good scienceDavid Culver-2/25/2004
223Stressgen reports HspE7 results from two clinical trials Tuesday February 24, 4:nigel bates-2/25/2004
222Nigel, the Fast Track news supports the StressGen/Roche HspE7 partnership rearraHeat Shock-12/7/2003
221Stressgen Receives FDA Fast Track Designation for HspE7 Thursday December 4, 7:5nigel bates-12/4/2003
220Stressgen and Roche broaden heat shock protein agreement to maximize value of Hsnigel bates-12/4/2003
219To all, another post (ID 6850231) by BioGold on <i>Was outHeat Shock-10/29/2003
218Thanks at this price stressgene seems like a good buy. To me it is got to be worDavid Culver-10/25/2003
217Following is the text of a post yesterday by BioBoffin (Post ID 68Heat Shock-10/25/2003
216To all: three high quality Stressgen posts appeared yesterday on Heat Shock-10/25/2003
215To All, a research report from June on StressGen/Roche delay for manufacturing rHeat Shock-9/29/2003
214Nature Publication by Conforma Therapeutics Scientists Identifies Molecular Mechnigel bates-9/24/2003
213the ICAAC PR - Stressgen presents results of pediatric Phase II RRP trial at ICnigel bates-9/16/2003
212To all, 2 notes from Tuesday's conference call: 1. RRP trial endpoints RRPHeat Shock-6/12/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):